With FDA nod on Uceris, Santarus puts out 'help wanted' sign for sales reps

Now that Santarus ($SNTS) has FDA approval in hand for its ulcerative colitis remedy Uceris, the company plans to staff up on the sales side, with 85 hires for its field force. Report